evidence table
Resveratrol Cognition Meta-Analysis Evidence Table
Structured evidence table for Resveratrol Cognition Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Cognition Meta-Analysis | Kaur et al., 2022 Figure 1 Figure 1 Ko et al., 2017 Tanwar et al., 2021 Qasem, 2020 Zhang et al., 2021 Resveratrol, a polyphenolic phytoalexin in the stilbene family, is commonly found in grape skins, red wine, peanuts, and certain berries (). | 1 | Wu Weidong (2025) | Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis |
| Resveratrol Cognition Meta-Analysis | Due to elevated follicle-stimulating hormone levels and significantly reduced estrogen levels, postmenopausal women face a variety of health challenges, including an increased risk of osteoporosis, mental health symptoms, cognitive decline, cardiovascular disease, and metabolic syndrome, all of which pose a substantial medical burden to both individuals and society (;). | 1 | Wu Weidong (2025) | Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis |
| Resveratrol Cognition Meta-Analysis | Additionally, studies indicate that postmenopausal women are at a higher risk of cardiovascular disease than their male counterparts or younger women (). | 1 | Wu Weidong (2025) | Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis |
| Resveratrol Cognition Meta-Analysis | Its chemical structure, consisting of two phenol rings connected by a styrene double bond and forming 3,4′,5-trihydroxy-trans-stilbene (left), which can exist in cis- or trans-isomeric forms, is similar to the synthetic estrogen diethylstilbestrol (right) (;). | 1 | Wu Weidong (2025) | Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis |
| Resveratrol Cognition Meta-Analysis | Observational associations between dietary patterns and reduced dementia risk have prompted investigations of dietary bioactives (DBs) as cognitive nutraceuticals. | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
| Resveratrol Cognition Meta-Analysis | Findings are synthesized qualitatively; no formal meta-analysis or risk of bias assessment was conducted. | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
| Resveratrol Cognition Meta-Analysis | Cannabinoids improved behavioral symptoms but showed no measurable cognitive effects. | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
| Resveratrol Cognition Meta-Analysis | Methods: This critical narrative review examines interventional trials for nine prominent DBs relevant to AD: docosahexaenoic acid (DHA), curcumin, resveratrol, epigallocatechin gallate (EGCG), nicotinamide riboside (NR), tricaprilin, vitamin E (α-tocopherol), cannabinoids, and NIC5-15 (D-pinitol). | 2 | Kumari A (2026) | Dietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies. |
Source documents